MagBiosense, Inc. is a private medical device company based in St. Louis, MO, specializing in the development of innovative diagnostic devices and assays. Their cutting-edge technology offers laboratory-quality sensitivity and the convenience of a point-of-care system, eliminating the need for additional detection steps.
With a focus on infectious diseases like Zika, dengue, and West-Nile viruses, MagBiosense's serological assays have demonstrated significantly higher sensitivity and specificity compared to traditional ELISA methods. Additionally, their high sensitivity detection of cardiac troponin I enables the rapid diagnosis and rule out of heart attacks in emergency departments.
Generated from the website
